Terms: = Ovarian cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1 AND Prognosis
31 results:
1. HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process.
Ma S; Wang J; Cui Z; Yang X; Cui X; Li X; Zhao L
Sci Rep; 2024 Feb; 14(1):3870. PubMed ID: 38365849
[TBL] [Abstract] [Full Text] [Related]
2. Effects of Autophagy-Related Genes on the prognosis and Immune Microenvironment of ovarian cancer.
Zhang J; Yan H; Fu Y
Biomed Res Int; 2022; 2022():6609195. PubMed ID: 35941978
[TBL] [Abstract] [Full Text] [Related]
3. A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer.
Zong S; Xu PP; Xu YH; Guo Y
J Ovarian Res; 2022 Aug; 15(1):90. PubMed ID: 35915456
[TBL] [Abstract] [Full Text] [Related]
4. PUMILIO-mediated translational control of somatic cell cycle program promotes folliculogenesis and contributes to ovarian cancer progression.
Li X; Zhu M; Zang M; Cao D; Xie Z; Liang H; Bian Z; Zhao T; Hu Z; Xu EY
Cell Mol Life Sci; 2022 May; 79(5):279. PubMed ID: 35507203
[TBL] [Abstract] [Full Text] [Related]
5. Analysis of the genomic landscape of yolk sac tumors reveals mechanisms of evolution and chemoresistance.
Zong X; Zhang Y; Peng X; Cao D; Yu M; Wang J; Li H; Guo X; Liang H; Yang J
Nat Commun; 2021 Jun; 12(1):3579. PubMed ID: 34117242
[TBL] [Abstract] [Full Text] [Related]
6. Exosomes released from M2 macrophages transfer miR-221-3p contributed to EOC progression through targeting cdkn1b.
Li X; Tang M
Cancer Med; 2020 Aug; 9(16):5976-5988. PubMed ID: 32590883
[TBL] [Abstract] [Full Text] [Related]
7. RUNX3 Promotes the Tumorigenic Phenotype in KGN, a Human Granulosa Cell Tumor-Derived Cell Line.
Chen H; Crosley P; Azad AK; Gupta N; Gokul N; Xu Z; Weinfeld M; Postovit LM; Pangas SA; Hitt MM; Fu Y
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311113
[TBL] [Abstract] [Full Text] [Related]
8. Genome-wide DNA copy number analysis in clonally expanded human ovarian cancer cells with distinct invasive/migratory capacities.
Li L; Bai H; Yang J; Cao D; Shen K
Oncotarget; 2017 Feb; 8(9):15136-15148. PubMed ID: 28122348
[TBL] [Abstract] [Full Text] [Related]
9. Upregulation of p27kip1 by demethylation sensitizes cisplatin-resistant human ovarian cancer SKOV3 cells.
Zhao Y; Li Q; Wu X; Chen P
Mol Med Rep; 2016 Aug; 14(2):1659-66. PubMed ID: 27314502
[TBL] [Abstract] [Full Text] [Related]
10. eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27kip1 translation.
Zhang Y; Yu JJ; Tian Y; Li ZZ; Zhang CY; Zhang SF; Cao LQ; Zhang Y; Qian CY; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2015 Sep; 6(28):25441-51. PubMed ID: 26213845
[TBL] [Abstract] [Full Text] [Related]
11. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.
Huang L; Wang HY; Li JD; Wang JH; Zhou Y; Luo RZ; Yun JP; Zhang Y; Jia WH; Zheng M
Cell Death Dis; 2013 Aug; 4(8):e745. PubMed ID: 23907459
[TBL] [Abstract] [Full Text] [Related]
12. Transgenesis-mediated reproductive dysfunction and tumorigenesis: effects of immunological neutralization.
Sachdeva R; Bhardwaj N; Huhtaniemi I; Aggrawal U; Jain SK; Zaidi R; Singh O; Pal R
PLoS One; 2012; 7(11):e51125. PubMed ID: 23226476
[TBL] [Abstract] [Full Text] [Related]
13. Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.
Gyorffy B; Lánczky A; Szállási Z
Endocr Relat Cancer; 2012 Apr; 19(2):197-208. PubMed ID: 22277193
[TBL] [Abstract] [Full Text] [Related]
14. Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.
Seeber LM; Horrée N; van der Groep P; van der Wall E; Verheijen RH; van Diest PJ
BMC Cancer; 2010 Jun; 10():307. PubMed ID: 20565904
[TBL] [Abstract] [Full Text] [Related]
15. Low expression of Foxo3a is associated with poor prognosis in ovarian cancer patients.
Fei M; Zhao Y; Wang Y; Lu M; Cheng C; Huang X; Zhang D; Lu J; He S; Shen A
Cancer Invest; 2009 Jan; 27(1):52-9. PubMed ID: 19160093
[TBL] [Abstract] [Full Text] [Related]
16. Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival.
Song H; Hogdall E; Ramus SJ; Dicioccio RA; Hogdall C; Quaye L; McGuire V; Whittemore AS; Shah M; Greenberg D; Easton DF; Kjaer SK; Pharoah PD; Gayther SA
Clin Cancer Res; 2008 Feb; 14(4):1090-5. PubMed ID: 18281541
[TBL] [Abstract] [Full Text] [Related]
17. Expression and prognostic significance of cyclin D3 in ovarian adenocarcinomas.
Levidou G; Korkolopoulou P; Thymara I; Vassilopoulos I; Saetta AA; Gakiopoulou H; Konstantinidou A; Kairi-Vassilatou E; Pavlakis K; Patsouris E
Int J Gynecol Pathol; 2007 Oct; 26(4):410-7. PubMed ID: 17885491
[TBL] [Abstract] [Full Text] [Related]
18. [DNA ploidy and results of first line chemotherapy in ovarian cancer patients].
Milczek T; Klasa-Mazurkiewicz D; Emerich J; Debniak J
Ginekol Pol; 2006 Aug; 77(8):589-96. PubMed ID: 17076189
[TBL] [Abstract] [Full Text] [Related]
19. Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer.
Rosen DG; Yang G; Cai KQ; Bast RC; Gershenson DM; Silva EG; Liu J
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):632-7. PubMed ID: 15701850
[TBL] [Abstract] [Full Text] [Related]
20. Thioredoxin modulates activator protein 1 (AP-1) activity and p27kip1 degradation through direct interaction with Jab1.
Hwang CY; Ryu YS; Chung MS; Kim KD; Park SS; Chae SK; Chae HZ; Kwon KS
Oncogene; 2004 Nov; 23(55):8868-75. PubMed ID: 15480426
[TBL] [Abstract] [Full Text] [Related]
[Next]
